Clinical Trial

9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer

Name: 9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer — clinical trial record (NCT07314723)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a single arm, open-label, multicenter phase II clinical study to evaluate the safety and efficacy of 9MW2821 combined with Toripalimab in perioperative patients with urothelial cancer.

Trial Details

NCT Number	NCT07314723
Lead Sponsor	Mabwell (Shanghai) Bioscience Co., Ltd.
Conditions	Urothelial Carcinoma
Enrollment	90 participants
Start Date	2025-08-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-02